Blockchain Registration Transaction Record

NeuroOne and Mayo Clinic Join Forces Against Childhood Brain Cancer

NeuroOne partners with Mayo Clinic to develop a novel drug delivery system for pediatric diffuse midline glioma, using convection-enhanced delivery and real-time neural recording to improve treatment outcomes.

This news matters because pediatric diffuse midline glioma is one of the most aggressive and difficult-to-treat childhood brain cancers, with limited treatment options. The collaboration between NeuroOne and Mayo Clinic, supported by the Children's Cancer Research Fund, aims to develop a novel therapy that could improve drug delivery to brain tumors, potentially increasing survival rates and quality of life for affected children. By combining precision drug delivery with real-time neural monitoring, this approach could set a new standard for treating brain cancers and other neurological disorders, offering hope to patients and families facing these devastating diagnoses.